![]() |
市場調查報告書
商品編碼
1750497
一次性手術器材市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測Disposable Surgical Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024年,全球一次性手術器械市場規模達64億美元,預計2034年將以8.8%的複合年成長率成長,達到150億美元。這主要得益於手術量的成長、感染控制措施的加強以及全球對微創手術日益成長的偏好。一次性器械因其高效、易用且易於保持無菌狀態而日益受到青睞。隨著已開發經濟體和新興經濟體的醫療保健系統不斷精簡營運流程並降低交叉污染風險,一次性手術器械正成為當務之急。向自動化和符合人體工學的先進器材的轉變進一步推動了其應用,尤其是在高通量醫療環境中。
疫情爆發後,醫療機構遵守更嚴格的感染控制政策。這加速了一次性手術解決方案的普及,尤其是在擇期和急診手術數量回升的情況下。這些器械在衛生方面具有顯著優勢,無需消毒步驟,並縮短了手術室的周轉時間。它們專為一次性使用場景設計,在注重速度和病人安全的手術環境中發揮著至關重要的作用。從基礎工具到先進的縫合器和套管針,一次性器械在確保無菌條件的同時,也能提高手術的一致性。
市場範圍 | |
---|---|
起始年份 | 2024 |
預測年份 | 2025-2034 |
起始值 | 64億美元 |
預測值 | 150億美元 |
複合年成長率 | 8.8% |
在產品類型中,手術縫線和縫合器領域在2024年以24億美元的市場規模領先市場。它們在傳統和微創手術中均已廣泛應用,是不可或缺的醫療工具。這些工具有助於傷口管理,確保傷口縫合牢固,最大限度地減少感染,並促進更快康復。人體工學設計、無需打結的倒鉤縫合線以及抗菌塗層等創新技術顯著提高了縫合線的安全性和效率,使其成為表現最佳的產品類別。
預計2034年,一般外科手術市場規模將達31億美元,複合年成長率為8.5%。此類別涵蓋多種手術,對一次性手術器械的需求持續成長。門診和住院干預的增加,以及慢性病和急性病的發生率不斷上升,正在推動對這些器械的需求。醫療機構依賴一次性手術器械來確保安全合規並簡化患者護理,尤其是在高容量環境中。
美國一次性手術器械市場規模在2024年達到20億美元,預計複合年成長率為7.7%。強大的監管框架、完善的醫療基礎設施以及優惠的報銷模式,都為一次性器械的快速普及提供了支援。此外,總部位於美國的大型醫療器材公司也持續推動市場的發展動能。
市場的主要參與者包括史密斯+侄子 (Smith+Nephew)、庫博 (CooperSurgical)、Xenco Medical、BD、強生 (Johnson & Johnson)、捷邁 (ZIMMER BIOMET)、貝朗 (B Braun)、美敦力 (Medtronic)、安布 (Ambu)、外科創新 (Surgifications) (Surgcut)、波士頓科學、安布 (Bocut)、外科創新。為了鞏固市場地位,各公司優先透過研發投資進行創新,以提高產品的可用性、安全性和性能。許多公司正在擴展產品組合,增加抗菌塗層和無結縫合線等智慧功能。與醫院和外科中心的策略合作也有助於確保供應合約並深化市場滲透。此外,製造商利用自動化和精密製造來滿足不斷成長的需求,同時保持成本效益,從而增強其在全球市場的競爭優勢。
The Global Disposable Surgical Devices Market was valued at USD 6.4 billion in 2024 and is estimated to grow at a CAGR of 8.8% to reach USD 15 billion by 2034, driven by increasing surgical volumes, heightened infection control measures, and the rising global preference for minimally invasive procedures. Disposable instruments are gaining traction due to their efficiency, ease of use, and ability to maintain sterile conditions. As healthcare systems across developed and emerging economies look to streamline operations and reduce the risk of cross-contamination, single-use surgical tools are becoming a top priority. The shift toward automation and ergonomically advanced tools further supports adoption, particularly in high-throughput medical settings.
In the wake of the pandemic, healthcare providers adhere to stricter infection control policies. This has accelerated the move toward disposable surgical solutions, particularly as the number of elective and emergency procedures rebounds. These instruments offer clear benefits in hygiene, eliminate sterilization steps, and reduce turnaround times in operating rooms. Designed for single-use scenarios, they are proving vital in surgical environments that demand both speed and patient safety. From basic tools to advanced staplers and trocars, disposables ensure sterile conditions while improving procedural consistency.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $6.4 Billion |
Forecast Value | $15 Billion |
CAGR | 8.8% |
Among product types, the surgical sutures and staplers segment led the market with USD 2.4 billion in 2024. Their consistent usage in both traditional and minimally invasive procedures makes them indispensable. These tools help in wound management, ensuring proper closure, minimizing infections, and aiding faster recovery. Innovations like ergonomic designs, barbed sutures requiring no knots, and antimicrobial coatings have significantly enhanced their safety and efficiency, making them the top-performing product category.
The general surgery segment is projected to reach USD 3.1 billion by 2034, growing at a CAGR of 8.5%. This category covers several procedures, contributing to consistent demand for disposable surgical tools. The increasing rate of outpatient and inpatient interventions, along with the growing prevalence of chronic and acute conditions, is boosting demand for these devices. Medical institutions rely on single-use surgical tools for safety compliance and streamlined patient care, especially in high-volume environments.
U.S. Disposable Surgical Devices Market accounted for USD 2 billion in 2024 and is expected to grow at a CAGR of 7.7%. A strong regulatory framework, sophisticated healthcare infrastructure, and favorable reimbursement models all support rapid adoption of disposable instruments. Additionally, major medical device companies headquartered in the U.S. continue to drive market momentum.
Key players in this market include Smith+Nephew, CooperSurgical, Xenco Medical, BD, Johnson & Johnson, ZIMMER BIOMET, B Braun, Medtronic, Ambu, Surgical Innovations, Accutome, and Boston Scientific. To strengthen their foothold, companies prioritize innovation through R&D investments to enhance usability, safety, and performance. Many are expanding product portfolios with smart features such as antimicrobial coatings and knotless sutures. Strategic collaborations with hospitals and surgical centers are also helping secure supply contracts and deepen market penetration. Furthermore, manufacturers leverage automation and precision manufacturing to meet growing demand while maintaining cost-efficiency, enhancing their competitive edge across global markets.